Inflammatory breast carcinoma (IBC). Clinical or pathological diagnosis?

被引:0
|
作者
Ruiz, A [1 ]
Climent, MA [1 ]
Lluch, A [1 ]
Olmos, T [1 ]
Lavernia, J [1 ]
Guillem, V [1 ]
机构
[1] Inst Valenciano Oncol, Med Oncol Serv, Valencia, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S57 / S57
页数:1
相关论文
共 50 条
  • [1] Inflammatory breast carcinoma (IBC). Clinical or pathological diagnosis?
    Ruiz, A
    Climent, MA
    Lluch, A
    Olmos, T
    Lavernia, J
    Guillem, V
    ANNALS OF ONCOLOGY, 1998, 9 : 8 - 8
  • [2] Inflammatory Breast Carcinoma: Pathological or Clinical Entity?
    Ruiz Simón Amparo
    Climent Durán Miguel Angel
    Lluch Hernandez Ana
    Llombart Cussac Antonio
    Moya Sahorí Vicente
    Fernandez-Martos Carlos
    Guillém Porta Vicente
    Breast Cancer Research and Treatment, 2000, 64 : 269 - 273
  • [3] Inflammatory breast carcinoma:: Pathological or clinical entity?
    Amparo, RS
    Angel, CDM
    Ana, LH
    Antonio, LC
    Vicente, MS
    Carlos, FM
    Vicente, GP
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 64 (03) : 269 - 273
  • [4] INFLAMMATORY CARCINOMAS OF THE BREAST - A CLINICAL, PATHOLOGICAL, OR A CLINICAL AND PATHOLOGICAL DEFINITION
    BONNIER, P
    CHARPIN, C
    LEJEUNE, C
    ROMAIN, S
    TUBIANA, N
    BEEDASSY, B
    MARTIN, PM
    SERMENT, H
    PIANA, L
    INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (04) : 382 - 385
  • [5] Inflammatory breast cancers (IBC)
    Hodkin, Leanne
    Horgan, Keiran
    Dodwell, David
    Sharma, Nisha
    BREAST CANCER RESEARCH, 2016, 18
  • [6] Inflammatory breast cancer (IBC) defined: Proposed common diagnostic criteria and scoring - Moving beyond the subjective 'clinical diagnosis' of IBC to advance research
    Mason, Ginny
    Overmoyer, Beth A.
    Woodward, Wendy A.
    Badve, Sunil
    Schneider, Robert J.
    Jagsi, Reshma
    Lang, Julie E.
    Alpaugh, Mary
    Smith, Krissa
    Miller, Kathy
    CANCER RESEARCH, 2020, 80 (04)
  • [7] Inflammatory Breast Carcinoma (IBC): Multiple Imaging Modalities for Monitoring of Response and Prediction of Pathological Residual Disease after Primary Chemotherapy
    Morandi, Paolo
    Whitman, Gary J.
    Gonzalez-Angulo, Ana M.
    Iyer, Revathy B.
    Sneige, Nour
    Booser, Daniel J.
    Kuerer, Henry M.
    Buchholz, Thomas A.
    Hortobagyi, Gabriel N.
    Cristofanilli, Massimo
    ANNALS OF ONCOLOGY, 2004, 15 : 35 - 35
  • [8] Correlation between clinical response according to WHO criteria and pathological response according to Chevallier and Sataloff in inflammatory breast cancer (IBC)
    Bonneterre, J.
    Mailliez, A.
    Giard, S.
    Chaveron, C.
    Belkacemi, Y.
    Vanlemmens, L.
    Baranzelli, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Inflammatory breast cancer (IBC) management
    Santoro, A
    Maiorino, L
    Santoro, M
    Quarto, G
    Forestieri, P
    10TH MEDITERRANEAN CONGRESS OF CHEMOTHERAPY, 1996, : 603 - 606
  • [10] Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome
    Dawood, Shaheenah
    Gong, Yun
    Broglio, Kristine
    Buchholz, Thomas A.
    Woodward, Wendy
    Lucci, Anthony
    Valero, Vicente
    Gonzalez-Angulo, Ana M.
    Hortobagyi, Gabriel N.
    Cristofanilli, Massimo
    BREAST JOURNAL, 2010, 16 (05): : 529 - 532